Excerpt from: SELLAS Announces Positive Data from Preclinical Studies Indicating ASXL1 Mutations as Predictor of Response to SLS009 in Solid Cancers
Excerpt from: SELLAS Announces Positive Data from Preclinical Studies Indicating ASXL1 Mutations as Predictor of Response to SLS009 in Solid Cancers
Read more here: Coherus Management to Participate in the 2024 Citi Global Healthcare Conference
Continue reading here: Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates
See the original post here: Revolution Medicines to Host RAS(ON) Inhibitor Clinical Update Webcast on December 2, 2024
The rest is here: Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference
Read the original post: QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
See original here: Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
Read the original here: Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
Read the rest here: Celularity Inc. Announces Receipt of Nasdaq Notification
Follow this link: Rakovina Therapeutics Announces Private Placement Offering
Recent Comments